Studies indicate that serum hyaluronic acid (HA) is a non-invasive marker of liver fibrosis (166), and serum YKL-40 can also be a marker of liver fibrosis in patients with NAFLD (167). The gene discussed is CHI3L1; the disease is metabolic dysfunction-associated steatotic liver disease.